197 related articles for article (PubMed ID: 33456564)
1. Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis.
Feng K; Ma C; Liu Y; Yang X; Yang Z; Chen Y; Xu T; Yang C; Zhang S; Li Q; Wei Z; Zhao D; Zeng P; Han J; Gao J; Chen Y; Duan Y
Theranostics; 2021; 11(6):2634-2654. PubMed ID: 33456564
[No Abstract] [Full Text] [Related]
2. Targeting macrophage liver X receptors by hydrogel-encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis.
Ma C; Feng K; Yang X; Yang Z; Wang Z; Shang Y; Fan G; Liu L; Yang S; Li X; Han J; Duan Y; Chen Y
Br J Pharmacol; 2021 Apr; 178(7):1620-1638. PubMed ID: 33506494
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of notch enhances the anti-atherosclerotic effects of LXR agonists while reducing fatty liver development in ApoE-deficient mice.
Hao Y; Wang X; Zhang F; Wang M; Wang Y; Wang H; Du Y; Wang T; Fu F; Gao Z; Zhang L
Toxicol Appl Pharmacol; 2020 Nov; 406():115211. PubMed ID: 32853627
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
5. Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy.
Ma C; Zhang W; Yang X; Liu Y; Liu L; Feng K; Zhang X; Yang S; Sun L; Yu M; Yang J; Li X; Hu W; Miao RQ; Zhu Y; Li L; Han J; Chen Y; Duan Y
Br J Pharmacol; 2018 May; 175(9):1486-1503. PubMed ID: 29394501
[TBL] [Abstract][Full Text] [Related]
6. 25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism.
Liu Y; Wei Z; Ma X; Yang X; Chen Y; Sun L; Ma C; Miao QR; Hajjar DP; Han J; Duan Y
J Lipid Res; 2018 Mar; 59(3):439-451. PubMed ID: 29298812
[TBL] [Abstract][Full Text] [Related]
7. Identification of interferon-γ as a new molecular target of liver X receptor.
Wang Q; Ma X; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao R; Hajjar DP; Duan Y; Han J
Biochem J; 2014 Apr; 459(2):345-54. PubMed ID: 24438183
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor-driven transcription of hepatic lipogenic genes in vivo.
Nahon JE; Groeneveldt C; Geerling JJ; van Eck M; Hoekstra M
Br J Pharmacol; 2018 Aug; 175(15):3175-3183. PubMed ID: 29774529
[TBL] [Abstract][Full Text] [Related]
10. Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol.
Liu Y; Wei Z; Zhang Y; Ma X; Chen Y; Yu M; Ma C; Li X; Cao Y; Liu J; Han J; Yang X; Duan Y
J Lipid Res; 2018 Dec; 59(12):2287-2296. PubMed ID: 30309895
[TBL] [Abstract][Full Text] [Related]
11. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
Kim JH; Jung DY; Kim HR; Jung MH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
[TBL] [Abstract][Full Text] [Related]
13. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of gomisin N against hepatic steatosis through AMPK activation.
Yun YR; Kim JH; Kim JH; Jung MH
Biochem Biophys Res Commun; 2017 Jan; 482(4):1095-1101. PubMed ID: 27914812
[TBL] [Abstract][Full Text] [Related]
15. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
[TBL] [Abstract][Full Text] [Related]
16. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator.
Miao B; Zondlo S; Gibbs S; Cromley D; Hosagrahara VP; Kirchgessner TG; Billheimer J; Mukherjee R
J Lipid Res; 2004 Aug; 45(8):1410-7. PubMed ID: 15145986
[TBL] [Abstract][Full Text] [Related]
17. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
19. Changes in LXR signaling influence early-pregnancy lipogenesis and protect against dysregulated fetoplacental lipid homeostasis.
Nikolova V; Papacleovoulou G; Bellafante E; Borges Manna L; Jansen E; Baron S; Abu-Hayyeh S; Parker M; Williamson C
Am J Physiol Endocrinol Metab; 2017 Oct; 313(4):E463-E472. PubMed ID: 28420650
[TBL] [Abstract][Full Text] [Related]
20. Hemistepsin A inhibits T0901317-induced lipogenesis in the liver.
Kim JK; Cho IJ; Kim EO; Lee DG; Jung DH; Ki SH; Ku SK; Kim SC
BMB Rep; 2021 Feb; 54(2):106-111. PubMed ID: 32843130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
